| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 01/24/2013 | US20130023521 Novel selective inhibitors of ubiquitin specific protease 7, the pharmaceutical compositions thereof and their therapeutic applications |
| 01/24/2013 | US20130023517 Therapeutic methods employing substituted piperidines which are CCR3 antagonists |
| 01/24/2013 | US20130023502 Substituted pyridinyl-pyrimidines and their use as medicaments |
| 01/24/2013 | US20130023499 Certain substituted amides, method of making, and method of use thereof |
| 01/24/2013 | US20130023497 Triazine Derivatives and their Therapeutical Applications |
| 01/24/2013 | US20130023492 Pharmaceutical compositions comprising plant-based polysaccharides and uses thereof |
| 01/24/2013 | US20130023489 Compositions and methods for preventing and treating diseases and environmentally induced health disorders |
| 01/24/2013 | US20130023485 Parenteral formulations of peptides for the treatment of systematic lupus erythematosus |
| 01/24/2013 | US20130023484 Peripherin-specific autoantibodies as a marker for neurological and endocrinological disease |
| 01/24/2013 | US20130023480 Purified Bowman-Birk Protease Inhibitor Proteins Isolated from a Soy Processing Sttream |
| 01/24/2013 | US20130022664 E.coli lpfa antigen for prevention and treatment of infectious diseases |
| 01/24/2013 | US20130022663 Method of making and using a topical medicated formula and delivery system to use to prevent and treat breast diseases and breast cancer as well as use as skin wellness and anti-wrinkle formula |
| 01/24/2013 | US20130022662 Compressed chewing gum tablet comprising taste-masking agent |
| 01/24/2013 | US20130022652 Stable medicated chewing gum comprising cyclodextrin inclusion complex |
| 01/24/2013 | US20130022642 Dual Antagonist for TNF-A and IL-21 for Preventing and Treating Autoimmune Diseases |
| 01/24/2013 | US20130022641 Anti-Tumor Agent and Immunostimulating Agent |
| 01/24/2013 | US20130022640 Immune modulators relating to foxo3a |
| 01/24/2013 | US20130022634 New composition and methods for treatment of autoimmune and allergic diseases |
| 01/24/2013 | US20130022633 MENINGOCOCCAL fHBP POLYPEPTIDES |
| 01/24/2013 | US20130022630 Method for treating amyloid disease |
| 01/24/2013 | US20130022629 Modulators of Immunoinhibitory Receptor PD-1, and Methods of Use Thereof |
| 01/24/2013 | US20130022628 Acyl pseudopeptides which carry a functionalized auxiliary arm |
| 01/24/2013 | US20130022616 Interleukin-31 Monoclonal Antibody |
| 01/24/2013 | US20130022614 IgE ANTIBODIES FOR THE TREATMENT OF CANCER |
| 01/24/2013 | US20130022605 Antagonists against tnfr1 and methods of use therefor |
| 01/24/2013 | US20130022602 Methods and compositions to modulate antiviral and immune activity responses |
| 01/24/2013 | US20130022583 Direct Conversion of Cells to Cells of Other Lineages |
| 01/24/2013 | US20130022580 Preparation and use of meristematic cells belonging to the dendrobium phalaenopsis, anisellia, polyrrhiza, vanilla, cattleya and vanda genera with high content of phenylpropanoids, hydrosoluble polysaccharides and extensins |
| 01/24/2013 | US20130022547 Attenuated mycoplasma gallisepticum strains |
| 01/24/2013 | US20130022544 Immunotherapeutic modulation of amyloidogenic disease using non-fibrillogenic, non-amyloidogenic polymerized proteins and peptides |
| 01/24/2013 | US20130022541 FTY720 Increases CD74 Expression and Sensitizes Cancer Cells to Anti-CD74 Antibody-Mediated Cell Death |
| 01/24/2013 | CA2842195A1 Fty720 increases cd74 expression and sensitizes cancer cells to anti-cd74 antibody-mediated cell death |
| 01/24/2013 | CA2842187A1 Heterocyclic compounds and uses thereof |
| 01/24/2013 | CA2842068A1 Isolated brachyspira and methods and compositions for expanding and isolating brachyspira |
| 01/24/2013 | CA2841887A1 4-imidazopyridazin-1-yl-benzamides and 4-imidazotriazin-1-yl-benzamides as btk - inhibitors |
| 01/24/2013 | CA2841886A1 4-imidazopyridazin-1-yl-benzamides and 4-imidazotriazin-1-yl-benzamides as btk-inhibitors |
| 01/24/2013 | CA2841164A1 Attenuated plasmodium with deactivated hmgb2 gene, as vaccine |
| 01/24/2013 | CA2841015A1 Dosage of dnak |
| 01/23/2013 | EP2548893A2 Dual antagonist for tnf- and il-21 for preventing and treating autoimmune diseases |
| 01/23/2013 | EP2548888A1 Periodontal-disease-specific peptide, and treatment and diagnosis of periodontal disease using same |
| 01/23/2013 | EP2548877A1 4-(5-Membered fused pyridinyl)benzamides as BTK-inhibitors |
| 01/23/2013 | EP2548863A1 New CRTh2 antagonists. |
| 01/23/2013 | EP2548575A1 Anti-CD19 antibodies that mediate ADCC for use in treating autoimmune diseases |
| 01/23/2013 | EP2548563A1 Anti-allergic composition |
| 01/23/2013 | EP2548457A1 Raw milk preparation for use for preventing or treating asthma and other allergic diseases in infants and children |
| 01/23/2013 | EP2547662A1 Pyrimidine derivatives for use as sphingosine 1-phosphate 1 (s1p1) receptor agonists |
| 01/23/2013 | EP2547366A2 Myeloid derived suppressor cell inhibiting agents |
| 01/23/2013 | EP2547361A1 Bacterial vaccine components from staphylococcus aureus and uses thereof |
| 01/23/2013 | EP2547328A2 Ccr7 ligand delivery and co-delivery in immunotherapy |
| 01/23/2013 | CN102892759A Nitrogen-containing heterocyclic compound having kynurenine production inhibitory activity |
| 01/23/2013 | CN102892422A Silicon-containing biodegradable material for anti-inflammatory therapy |
| 01/23/2013 | CN102892417A Compounds for immunoproteasome inhibition |
| 01/23/2013 | CN102887948A Antibacterial and immunoregulation polypeptide medicine |
| 01/23/2013 | CN102887829A Method for preparing fingolimod mucate and crystals thereof and application of fingolimod mucate and crystals thereof |
| 01/23/2013 | CN102886032A Preparation method of oral liquid for treating cold |
| 01/23/2013 | CN102885965A Chinese medicinal preparation for treating allergic rhinitis |
| 01/23/2013 | CN102885959A Method for preparing garlicin and application of garlicin |
| 01/23/2013 | CN102885917A Rhizome atractylodis macrocephalae and fructus aurantii immaturus compound oral liquid capable of regulating qi stagnation by alleviating mental depression and preparation technology thereof |
| 01/23/2013 | CN102885882A Honeycomb and eupolyphaga agent for skin |
| 01/23/2013 | CN102885879A Method for producing yupingfeng lyophilized powder capsule |
| 01/23/2013 | CN102885865A Antiallergic tablet |
| 01/23/2013 | CN102885860A Ganoderma lucidum spore oil soft capsule for strengthening immunity and preparation method of soft capsule |
| 01/23/2013 | CN102885854A Taiwanese green propolis extractants used for the purpose of slowing down progression of disease of patient |
| 01/23/2013 | CN102885832A Application of Gypensapogenin A in medicine for treating rhinitis |
| 01/23/2013 | CN102885794A Buccal interferon tablet and preparation method thereof |
| 01/23/2013 | CN102885791A Method for preparing fexofenadine hydrochloride orally disintegrating tablet |
| 01/23/2013 | CN102885767A Novel olopatadine hydrochloride eye drop and preparation method thereof |
| 01/23/2013 | CN102885761A Method for preparing tacrolimus ointment |
| 01/23/2013 | CN102885758A Method for using desloratadine |
| 01/23/2013 | CN102885742A Fleece flower root wet wipe for wiping hair and scalp and preparation method of fleece flower root wet wipe |
| 01/23/2013 | CN102885718A Honeysuckle flower compound mosquito repellent and preparation method thereof |
| 01/23/2013 | CN102885301A Composition for enhancing immunity and preparation method thereof |
| 01/23/2013 | CN102440959B Pidotimod liposome solid preparation |
| 01/23/2013 | CN102274443B Compound Chinese medicinal microemulsion preparation capable of improving immunity |
| 01/23/2013 | CN102247420B Preparation method and application of eclipta extract |
| 01/23/2013 | CN102205111B Application of agrocybe aegerita galactose agglutinin in preparation of anti-HIV (Human Immunodeficiency Virus) infection medicament |
| 01/23/2013 | CN102191153B Burdock-water caltrop pulp health wine and production method thereof |
| 01/23/2013 | CN102020607B 6-aminoniacinamide derivatives with histone deacetylase inhibiting activity, preparation method and application thereof |
| 01/23/2013 | CN101987866B Staphylococcus aureus Efb protein C-end antigen epitope, as well as preparation method and usage thereof |
| 01/23/2013 | CN101816701B Process for preparing kudzu root extract instant grains |
| 01/23/2013 | CN101735918B Selenium-rich health wine and production method thereof |
| 01/23/2013 | CN101698089B Traditional Chinese medicine volatile oil inclusion complex and preparation method thereof |
| 01/23/2013 | CN101657192B Medicinal composition, food or drink having effect of enhancing parasympathetic nervous actions |
| 01/23/2013 | CN101422529B Preparation method of traditional Chinese medicine preparation |
| 01/23/2013 | CN101210244B Neutrokine-alpha and Neutrokine-alpha splice variants |
| 01/22/2013 | US8357493 Method for detecting mycobacteria using deleted sequences in M. bovis BCG/M. bovis or tuberculosis |
| 01/22/2013 | US8357372 Agent for treating allergic or hypersensitivity condition |
| 01/22/2013 | US8357370 Anti-D monoclonal antibodies |
| 01/22/2013 | CA2771215C Therapeutic preparation for rhinitis |
| 01/22/2013 | CA2653939C Immunostimulatory oligonucleotides and use thereof in pharmaceuticals |
| 01/22/2013 | CA2483819C Non-immunosuppressive imunogenic or vaccine composition comprising a mutated e7 protein of the hpv-16 virus |
| 01/22/2013 | CA2441663C Viral vectors and their use in therapeutic methods |
| 01/22/2013 | CA2425862C Cd19-specific redirected immune cells |
| 01/22/2013 | CA2375619C Equine granulocyte-macrophage colony-stimulating factor (gm-csf) |
| 01/22/2013 | CA2325629C Crystalline forms of 1s-[1alpha (2s*,3r*), 9alpha]-6, 10-dioxo-n- (2-ethoxy-5 -oxo-tetrahydro-3 -furanyl) -9-[[(1-isoquinolyl) carbonyl]-amino] octahydro-6h -piridazino[1, 2-a][1,2] diazepin- 1-carboxamide |
| 01/22/2013 | CA2290078C Erysipelothrix rhusiopathiae antigens and vaccine compositions |
| 01/17/2013 | WO2013009586A1 Topical minocycline ointment for suppression of allergic skin responses |
| 01/17/2013 | WO2013009519A2 Materials for treating and preventing mucosa related disease |
| 01/17/2013 | WO2013008171A1 Antibodies that bind to ox40 and their uses |
| 01/17/2013 | WO2013007768A1 Tricyclic heterocyclic compounds, compositions and methods of use thereof as jak inhibitors |